Potential biomarkers for head and neck squamous cell carcinoma

Laryngoscope

Volumn 113, Issue 3, 2003, Pages 393-400

  Brown, Jimmy J ^a   Xu, Helen ^a   Nishitani, Junko ^a   Mohammed, Hezla ^a   Osborne, Ryan ^a   Teklehaimanot, Senait ^a   Gill, Gus ^a   Liu, Xuan ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Biomarkers; Head and neck squamous cell carcinoma; Immortalized; Metallothionein; Premalignant

Indexed keywords

BENZO[A]PYRENE; COMPLEMENTARY DNA; GENE PRODUCT; METALLOTHIONEIN; TUMOR MARKER;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER RECURRENCE; CARCINOGENESIS; CELL IMMORTALIZATION; CELL SPECIFICITY; CLONE; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LARYNX CARCINOMA; MALE; NORTHERN BLOTTING; PRECANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; RNA HYBRIDIZATION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; WART VIRUS;

BACTERIAL PROTEINS; BACTERIAL TOXINS; BLOTTING, NORTHERN; CARCINOMA, SQUAMOUS CELL; CELL CULTURE TECHNIQUES; CLONE CELLS; DNA, COMPLEMENTARY; ESCHERICHIA COLI PROTEINS; FEMALE; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; METALLOTHIONEIN; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RNA;

EID: 0037334813     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200303000-00001     Document Type: Article

References (20)

1. Parkin DM, Pisani P, Lopez AD, Masuyer E. At least one in seven cases of cancer is caused by smoking: global estimates for 1985. Int J Cancer 1994;59:494-504.
2. Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics. CA Cancer J Clin 1994;44:7-26.
3. Schantz SP, Harrison LB, Hong WK. Tumors of the nasal cavity and paranasal sinuses, nasopharynx, oral cavity and oropharynx. In: Devita VT Jr, Helman S, Rosemberg SA, eds. Cancer: Principles and Practice of Oncology. Philadelphia: JB Lippincott, 1993:574-630.
4. Galloway DA. Papillomavirus capsids: a new approach to identify serological markers of HPV infection. J Natl Cancer Inst 1994;86:474-475.
5. Mineta H, Ogino T, Amano HM, et al. Human papilloma virus (HPV) type 16 and 18 detected in head and neck squamous cell carcinoma. Anticancer Res 1998;18:4765-4768.
6. Parker MF, Arroyo GF, Geradts J, et al. Molecular characterization of adenocarcinoma of the cervix. Gynecol Oncol 1997;64:242-251.
7. Park N-H, Min BM, Li SL, Huang MZ, Cherrick HM, Doniger J. Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogen 1991;12:1627-1631.
8. Park N-H, Gujuluva CN, Baek JH, Cherrick HM, Shin KH, Min BM. Combined oral carcinogenecity of HPV-16 and benzo(a)pyrene: an in vitro multistep carcinogenesis model. Oncogene 1995;10:2145-2153.
9. Rheinwald JG, Beckett MA. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res 1981;41:1657-1663.
10. Min BM, Kim K, Cherrick HM, Park N-H. Three cell lines from hamster buccal pouch tumors induced by topical 7,12-dimethylbenz(a)anthracene, alone or in conjunction with herpes simplex virus inoculation. In Vitro Cell Dev Biol 1991;27A:128-136.
11. Gioanni J, Fischel JL, Lambert JC, et al. Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: established, characterization and response to cytotoxic treatment. Eur J Cancer Clin Oncol 1988;24:1445.
12. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusening NE. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988;106:761-771.
13. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. 1992;257:967-971.
14. Altschul SF, Madden TL, Schaffer AA, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucl Acids Res 1997;25:3389-3402.
15. Gulley ML. Molecular diagnosis of Epstein-Barr virus-related diseases. J Mol Diagn 2001;3:1-10.
16. Chauvin RJ, Cherian MG, Wysochi GP, et al. A comparison of metallothionein expression in human normal and neoplastic salivary gland tissue using immunohistochemistry. Toxicologist 1992;12:379.
17. Cherian MG, Huang PC, Klaassen CD, et al. National Cancer Institute workshop on possible roles of metallothionein in carcinogenesis. Cancer Res 1993;53:922-925.
18. Ebert MPA, Gunther T, Hoffman J, et al. Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer. Cancer Res 2000;60:1995-2001.
19. Izawa JI, Mousa M, Cherian MG, et al. Metallothionein expression in renal cancer. Urology 1998;51:767-771.
20. Muramatsu Y, Hasegawa Y, Fukano H, et al. Metallothionein immunoreactivity in head and neck carcinomas: special reference to clinical behaviors and chemotherapy responses. Anticancer Res 2000;1A:257-264.